Dermatology Times Newsletter

To view this email as a web page, click here.

You’re reading the latest from Dermatology Times. Our mission is to provide you with clinical insights that expand your expertise and advance your practice. Connect with us on Twitter and Facebook for daily updates.

Advocating for dermatology

Changes are coming that may affect the practice of dermatology, but dermatologists can help to influence that change by participating in key initiatives. In this article, we highlight the three different initiatives you should have on your radar.

A look into the future of dermatology

The global dermatology devices market will continue to grow through 2027 with a rise in aesthetic procedures, an increasing need for early diagnosis and additional growth and investment opportunities.

PLUS: 3 ways to improve the patient experience

From Medical Economics
From booking first appointments to follow-ups and final billing, providers should consider how they can make the patient experience better.

Radiofrequency needling, CO2 laser, or both?

With an array of lasers available to address superficial and deep wrinkles, age spots, and more, how can you confidently select the right technology to provide the clinical results your patients want to see?

Listen to this podcast for to find out more.

From our Latest Issue

Examining the prejuvenation trend

In-office Rx dispensing fills care gap

Research program explores energy for lesion treatment

JOB OPPORTUNITIES

CA - Integrated Dermatology

CO-Integrated Dermatology

CT - Integrated Dermatology

District of Columbia-Integrated Dermatology

MA - Integrated Dermatology

MD - Integrated Dermatology

MS - Integrated Dermatology

National - Integrated Dermatology

NJ - Integrated Dermatology

NJ - Practice for Sale

NV - Integrated Dermatology

VA - Integrated Dermatology

VT - Integrated Dermatology

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.